Skip to main content

News stories

Response to the second phase review into patient safety

Published on 30/06/2023

A statement on behalf of Dame Yve Buckland, Chair and Jonathan Brotherton, Interim Chief Executive:

“We are listening, learning and welcome the additional assurance and support that has been provided through the independent oversight of Prof. Mike Bewick and his team; we thank them for their second report.

“We have taken the concerns raised to date incredibly seriously and have reflected, reviewed and reset; openly acknowledging and accepting our failings. We will approach any new lines of enquiry that are raised within this second report in the same way.

“Not wishing to wait solely for the findings and recommendations from the external reviews, a series of bold – but necessary and fundamental – changes have already been made to put us back on a positive path.

“Our unstinting focus is on providing the best possible patient care to our patients, building a values-led culture and supporting our 24,000 incredible colleagues.”

See the downloads section to read a summary of action and progress taken by UHB from December 2022 to June 2023 and the second phase of the review into patient safety.

More news

Pioneering double lung transplant gives patient new lease of life

Pioneering double lung transplant gives patient new lease of life

Joseph McConnell is sharing his extraordinary story to encourage more people to register as organ donors.
New research facility opens at Good Hope Hospital

New research facility opens at Good Hope Hospital

A new research facility at Good Hope Hospital is now open to patients. Located on the former CU27 ward, it provides dedicated space for interventional research, giving more of our patients the opportunity to take part in clinical trials.
UHB launches Midlands first dedicated clinic for rare genetic sight loss condition

UHB launches Midlands first dedicated clinic for rare genetic sight loss condition

University Hospitals Birmingham NHS Foundation Trust (UHB) has launched a dedicated clinic for people with Leber Hereditary Optic Neuropathy (LHON), a rare inherited condition that can cause severe sight loss and blindness.
Read more news